Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.

Guo, Haixiu; Chen, Xiuhua; Tian, Ruiyuan; Chang, Jianmei; Li, Jianlan; Tan, Yanhong; Xu, Zhifang; Ren, Fanggang; Zhao, Junxia; Pan, Jie; Zhang, Na; Wang, Xiaojuan; He, Jianxia; Yang, Wanfang; Wang, Hongwei

Guo, Haixiu; Chen, Xiuhua; Tian, Ruiyuan; Chang, Jianmei; Li, Jianlan; Tan, Yanhong; Xu, Zhifang; Ren, Fanggang; Zhao, Junxia; Pan, Jie; Zhang, Na; Wang, Xiaojuan; He, Jianxia; Yang, Wanfang; Wang, Hongwei.

Afiliação

Guo H; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China; Department of Microbiology and Immunology, School of Basic Medicine, Shanxi Medical University, Taiyuan, China.
Chen X; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Tian R; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Chang J; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Li J; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Tan Y; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Xu Z; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Ren F; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Zhao J; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Pan J; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Zhang N; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Wang X; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
He J; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Yang W; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Wang H; Institute of Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, China.

PLoS One ; 10(9): e0138250, 2015.

Article em En | MEDLINE | ID: mdl-26375990

Assuntos

Calreticulina/genética; Granulócitos/patologia; Janus Quinase 2/genética; Mutação/genética; Transtornos Mieloproliferativos/genética; Trombocitemia Essencial/genética; Adolescente; Adulto; Idoso; Idoso de 80 Anos ou mais; Alelos; China/epidemiologia; Estudos de Coortes; Feminino; Seguimentos; Granulócitos/metabolismo; Humanos; Masculino; Pessoa de Meia-Idade; Transtornos Mieloproliferativos/epidemiologia; Transtornos Mieloproliferativos/patologia; Fenótipo; Reação em Cadeia da Polimerase; Prognóstico; Receptores de Trombopoetina/genética; Trombocitemia Essencial/epidemiologia; Trombocitemia Essencial/patologia; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Calreticulina / Janus Quinase 2 / Granulócitos / Trombocitemia Essencial / Mutação / Transtornos Mieloproliferativos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google